Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

The blockchain in drug discovery and clinical trials market is anticipated to grow at a CAGR of over 20% till 2035, claims Roots Analysis

This image opens in the lightbox

News provided by

Roots Analysis

23 Feb, 2023, 15:05 GMT

Share this article

Share toX

Share this article

Share toX

Blockchain has emerged as a viable solution for management / exchange of large volumes of healthcare data, demonstrating significant benefits in the healthcare industry.

LONDON, Feb. 23, 2023 /PRNewswire/ --  Roots Analysis has announced the addition of "Blockchain Technology in Healthcare Industry Market (Focus on Drug Discovery and Clinical Trials), 2023-2035" report to its list of offerings.

Despite the growing interest of stakeholders in blockchain technology, the applicability of blockchain in healthcare is associated with several challenges, including scalability issues, lack of security and cyber-attacks. In order to deal with the aforementioned challenges, organizations have established transparency and privacy to conceal sensitive patient data. Further, the technology has demonstrated tremendous potential in clinical research and trials enhancing the possibility of secure sharing of accurate data thereby simplifying clinical trial operations. Driven by the promising potential of blockchain technology in the provision of personalized, authentic and reliable clinical trial services, the market is anticipated to gain significant traction in the foreseen future.

To order this 160+ page report, which features 70+ figures and 80+ tables, please visit.

https://www.rootsanalysis.com/reports/blockchain-technology-in-healthcare-market.html 

Key Market Insights

More than 50 blockchain technology providers currently offer blockchain platforms for various drug development applications

Majority of the blockchain technology providers (59%) offer their proprietary blockchain platforms for clinical trial management. This is followed by players offering blockchain for drug supply chain (47%), followed by electronic health record management (27%) and drug discovery (25%).

Over 50% blockchain technology providers are headquartered in North America

Blockchain in drug discovery and clinical trials market is dominated by the presence of small players (39%). This is followed by mid-sized players (27%). In addition, majority of the blockchain technology providers headquartered in North America have been established post-2010.

Partnership activity in this market has increased at a CAGR of 63% during the period 2017-2021 

Platform utilization agreements emerged as the most popular type of partnership model adopted by blockchain technology providers, representing over 40% of the total instances. In addition, 21% of the partnerships in this domain were inked in 2021.

Close to 500 articles focused on blockchain, have been published in reputed scientific journals, since 2016

More than 70% of the articles focused on blockchain were published post-2020. Popular journals that have published multiple articles include Journal of Medical Internet Research, Sensors, Frontiers and International Journal of Environmental Research and Public Health.

Blockchain in Drug Discovery and Clinical Trials Market is anticipated to grow at a CAGR of over 20% by 2035

Asia-Pacific is anticipated to capture over 45% of the overall market share for blockchain. This is followed by North America, with a share of over 20%. Further, in terms of type of blockchain, public blockchain (41%) is anticipated to capture the highest share in the foreseen future

To request a sample copy / brochure of this report, please visit

https://www.rootsanalysis.com/reports/blockchain-technology-in-healthcare-market/request-sample.html

Key Questions Answered

  • What is Blockchain and How Does it Work?
  • What is the Future Potential of Blockchain in Healthcare?
  • Which Pharmaceutical Companies are using Blockchain?
  • What are the Key Value Drivers of Blockchain Market in Drug Discovery and Clinical Trials?
  • What is the Current Market Landscape of the Blockchain Market Focused on Drug Discovery and Clinical Trials?
  • What are the Key Advantages Offered by Novel Blockchain Platforms in Drug Discovery and Clinical Trials?
  • What are the Key Trends in the Blockchain in Drug Discovery and Clinical Trials Market?
  • What is the Market Size of Blockchain in Drug Discovery and Clinical Trials Market?
  • Who are the Key Players in the Blockchain in Drug Discovery and Clinical Trials Market?

The financial opportunity within the blockchain in drug discovery and clinical trials market has been analyzed across the following segments:

  • Type of Blockchain
    • Public Blockchain
    • Private Blockchain
    • Hybrid Blockchain
    • Other Blockchains
  • Type of End-User
    • Hospitals
    • Pharmaceutical Industry
    • Research Institutes
    • Academic Institutes
  • Key Geographical Regions
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

The research also includes detailed profiles of the key players (listed below, in alphabetic order) providing blockchain in drug discovery and clinical trials; each profile features an overview of the company, its financial information (if available), applications of its proprietary platform, recent developments and an informed future outlook.

  • Alten Calsoft Labs
  • ConsenSys
  • Humanscape
  • Hyperledger Foundation
  • IBM
  • Infosys
  • Innoplexus
  • Medsphere
  • Solulab
  • Stratumn
  • Tech Mahindra

For additional details, please visit 

https://www.rootsanalysis.com/reports/blockchain-technology-in-healthcare-market.html

or email sales@rootsanalysis.com

You may also be interested in the following titles:

1.  Biosensors Market: Focus on Drug Discovery and Development, 2022-2035

2.  AI-based Drug Discovery Market (2nd Edition), 2022-2035

3.  Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market, 2022-2035

                       

Contact:

Gaurav Chaudhary 
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com 

Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.